SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: crysball who wrote (1040)7/17/1998 9:13:00 PM
From: Zvi Steinberg  Respond to of 1491
 
Neil,
Could'nt have said it better myself. Wish I had some free cash available to buy more.
Best regards,
Zvi



To: crysball who wrote (1040)7/18/1998 7:46:00 AM
From: Omer Shvili  Read Replies (1) | Respond to of 1491
 
You can be sure that if PARS will raise money in the future, it will not come from the like of Castle Creek.
Currently, PARS has two approved drugs, one more entering phase III and HU211 in late phase II. At this stage, PARS will not need to raise money from hedge funds. If the company will raise additional funds (I hope and believe they won't), it will be done with a large investment bank.
Bob Cook (CFO) said that such private offerings are a thing of the past, and we won't see any more in the future.
I believe that PARS won't need to raise additional funds. A partner for HU211 will pay an up front fee, which will be sufficient. With the cash from such a deal, PARS will start posting positive cash flow before it runs out of cash.

Omer



To: crysball who wrote (1040)7/20/1998 8:35:00 PM
From: arnie h  Read Replies (1) | Respond to of 1491
 
Crysbal: Hard to believe management didn't appreciate the ramifications of the private placements they made. For one, there were numerous postings on this thread that pointed out the obvious. For another, management took the path of writing into the agreement some things about obeying the laws of the land. Unfortunately, some of these hedge funders are located off shore and probably wouldn't pay attention even if they weren't. A further point is that the management of PARS seems to be comprised of pretty bright,wordly fellows; it is hard to believe they would have raised money the way they did if they could have done otherwise. Plainly, the value of PARS at the time was not appealing to other than the kind of people with whom they wound up. The alternative explanation involves chicanery which I've tended to discount.

We'll know in about 6 months whether 'better' money can be raised
since we'll be out in 1Q'99 according to the latest 10Q.

Regards,

Arnie H